Pull 4 Parkinson’s Foundation, Inc., a registered 501(c)(3) public charity,
funds cure and care research conducted by the Parkinson's disease community.
Learn More or Donate.

Research and Markets: Global Parkinson’s Disease Drug Pipeline Capsule - 2012 Update

Fore Pharma's latest report 'Global Parkinson's Disease Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Parkinson's Disease market. It covers active Parkinson's Disease pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Key Features of the Report:

- Parkinson's Disease: Overview

- Parkinson's Disease Pipeline Overview

- Parkinson's Disease Phase 3 Clinical Trial Pipeline Insights

- Parkinson's Disease Phase 2 Clinical Trial Pipeline Insights

- Parkinson's Disease Phase 1 Clinical Trial Pipeline Insights

- Parkinson's Disease Preclinical Research Pipeline Insights

- Parkinson's Disease Discovery Stage Pipeline Insights

- Geographic Landscape of Parkinson's Disease R&D Activities

- Parkinson's Disease R&D Activities in North America

- Parkinson's Disease R&D Activities in Europe

- Licensing Activities / Partnerships

Key Topics Covered:

1. Parkinson's Disease - Disease Overview

2. Parkinson's Disease Pipeline Overview

3. Parkinson's Disease Phase 3 Clinical Trial Pipeline Insights

4. Parkinson's Disease Phase 2 Clinical Trial Pipeline Insights

5. Parkinson's Disease Phase 1 Clinical Trial Pipeline Insights

6. Parkinson's Disease Preclinical Research Pipeline Insights

7. Parkinson's Disease Discovery Stage Pipeline Insights

8. Parkinson's Disease Drug Development Activities - Geographic Landscape

8.1. Parkinson's Disease R&D Activities in North America

8.2. Parkinson's Disease R&D Activities in Europe

9. Parkinson's Disease Pipeline - Licensing Activities

For more information visit http://www.researchandmarkets.com/research/6lkdr4/global

 

Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Comments

Article’s News Categories:

Related Articles: